- Home
- SAN vs BSX Comparison
SAN vs BSX Comparison
Compare SAN & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAN
- BSX
- Stock Information
- Founded
- SAN 1857
- BSX 1979
- Country
- SAN Spain
- BSX United States
- Employees
- SAN 206736
- BSX N/A
- Industry
- SAN Commercial Banks
- BSX Medical/Dental Instruments
- Sector
- SAN Finance
- BSX Health Care
- Exchange
- SAN Nasdaq
- BSX Nasdaq
- Market Cap
- SAN 123.4B
- BSX 138.4B
- IPO Year
- SAN 1987
- BSX 1992
- Fundamental
- Price
- SAN $8.54
- BSX $104.32
- Analyst Decision
- SAN Strong Buy
- BSX Strong Buy
- Analyst Count
- SAN 1
- BSX 22
- Target Price
- SAN N/A
- BSX $112.86
- AVG Volume (30 Days)
- SAN 7.6M
- BSX 8.0M
- Earning Date
- SAN 07-23-2025
- BSX 07-23-2025
- Dividend Yield
- SAN 1.97%
- BSX N/A
- EPS Growth
- SAN 20.30
- BSX 15.23
- EPS
- SAN 0.87
- BSX 1.37
- Revenue
- SAN $54,835,711,180.00
- BSX $17,554,000,000.00
- Revenue This Year
- SAN $23.44
- BSX $17.50
- Revenue Next Year
- SAN $2.47
- BSX $10.75
- P/E Ratio
- SAN $9.24
- BSX $76.12
- Revenue Growth
- SAN 6.36
- BSX 19.36
- 52 Week Low
- SAN $4.27
- BSX $71.88
- 52 Week High
- SAN $8.55
- BSX $107.53
- Technical
- Relative Strength Index (RSI)
- SAN 65.09
- BSX 54.04
- Support Level
- SAN $8.02
- BSX $102.67
- Resistance Level
- SAN $8.30
- BSX $107.53
- Average True Range (ATR)
- SAN 0.14
- BSX 1.82
- MACD
- SAN 0.02
- BSX 0.28
- Stochastic Oscillator
- SAN 100.00
- BSX 66.32
About SAN Banco Santander S.A. Sponsored ADR (Spain)
Santander's focus is on retail and commercial banking. Latin America is geographically the most significant operation, with Brazil making the largest contribution. Its continental European business is mainly in Spain and Portugal. Santander's UK presence is the result of its acquisition of Abbey building society. In the US, Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.